Skip to main content

Table 1 Laboratory studies. Patient laboratory values are displayed for the patient for the ranges from hospitalizations at our institution with the normal value ranges for each indicated test listed

From: Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares

Test

Normal Values

Patient’s Values

Biochemical

 ALT

5–41 IU/L

165–615

 AST

6–40 IU/L

44–157

 GGT

15–85 IU/L

30–405

 Total bilirubin

0.0–1.1 mg/dL

0.2

 INR

< 1.0

1.2–1.6

 Fibrinogen

230–450 mg/dL

57–493

 D-dimer

≤0.5 mg FEU/mL

> 20

 Ceruloplasmin

29–56 mg/dL

48

 Liver copper

10–35 μg/g dry weight

43

 Plasma copper

56–191 mcg/dL

191

 Triglycerides

60–135 mg/dL

95–503

 LDL

< 110 mg/dL

324

 HDL

> 39 mg/dL

58

 Total LDH

145–345 U/L

5490–28,019

 LDH 1 (%)

17.5–28.3% (I, Heart)

7.5–10

 LDH 2 (%)

30.4–36.4% (II)

17.6–21

 LDH 3 (%)

19.2–24.8% (III)

26.9

 LDH 4 (%)

9.6–15.6% (IV)

23.7

 LDH 5 (%)

5.5–12.7% (V, Liver)

24.3

 Ferritin

10–300 ng/mL

555–4264

 sIL-2R

45–1105 U/mL

145

Immunological

 IgG

608–1572 mg/dL

1050–1140

 IgA

52–242 mg/dL

261

 IgM

45–236 mg/dL

89–108

 IgE

0.98–570.6 mg/dL

105

 IgD

≤10 mg/dL

3

 PPSV23 (PCV13)

≥8/21 (≥5/12)

8/21 (5/12)

 Tetanus

≥0.01 IU/mL

0.43

 C3

83–203 mg/dL

186

 C4

16–52 mg/dL

24

 CH50

> 32 unit/mL

69

 CD3

1200-2600/mm3

6086; 1465

 CD4

650–1500/mm3

3793; 786

 CD8

370–1100/mm3

2117; 661

 CD4:CD8

> 2:1

1:8:1; 1.2:1

 CD16+CD56+

120–480/mm3

882; 89

 CD19

270–860/mm3

1588; 232

 PHA

> 30%

24.70%

 anti-CD3

> 30%

21.50%

NK function

 50:1

> 20

11

 25:1

> 10

9

 12.5:1

> 5

5

 6.25:1

> 1

5

 Lytic units

> 3.1

2.5

  1. Abbreviations: ALT Alanine aminotransferase, AST Aspartate aminotransferase, CH50 Total hemolytic complement activity, GGT γ-glutamyl transferase, HDL High density lipoprotein, IgA Immunoglobulin A, IgD Immunoglobulin D, IgG Immunoglobulin G, IgM Immunoglobulin M, INR International normalized ratio, LDH Lactate dehydrogenase, LDL Low density lipoprotein, NK Natural killer cell, PHA Phytohemagglutinin, PPSV23 Pneumococcal vaccine polyvalent, sIL-2R Soluble interleukin-2 receptor